Studies on sporadic non-syndromic thoracic aortic aneurysms: II. Alterations of extra-cellular matrix components and focal adhesion proteins

Abstract

Background

Sporadic non-syndromic thoracic aortic aneurysms (SNSTAAs) are less well understood than familial non-syndromic or syndromic ones. Here, we focused on morphologic and molecular changes of the extracellular matrix of the tunica media of SNSTAAs.

Design

Single centre design.

Methods

Surgical media samples from seven SNSTAAs and seven controls underwent quantitative polymerase chain reaction, proteomics-bioinformatics, immunoblotting, histology and immunohistochemistry analysis.

Results

A down-regulation of Decorin mRNA with unchanged protein levels associated with a remarkable increase of collagen fibres. A reduced and distorted network of elastic fibres partnered with an attenuated expression of microfibril-associated glycoprotein1 despite the rise of MFAP2 gene-encoded mRNA levels. An increasingly proteolysed paxillin (55 kDa PXN), a focal adhesion protein, combined with an upregulated 62 kDa PXN holoprotein, without changes in amount and phosphorylation of focal adhesion kinase (pp125^FAK). The upregulation of SPOCK2-encoded Testican2 proteoglycan and of ectodysplasin (EDA) protein was coupled with a down-regulation of EDA2 receptor (EDA2R).

Conclusions

Several tunica media extracellular matrix-related changes favour SNSTAA development. A steady level of decorin and a microfibril-associated glycoprotein1 protein shortage cause the assembly of structurally defective collagen and elastic fibres. Up-regulation of PXN holoproteins perturbs PXN/pp125^FAK interaction and focal adhesion functioning. Testican2 up-regulation suppresses the membrane-type matrix metalloproteinase inhibiting activities of other SPOCK family members thus enhancing extracellular matrix proteolysis. Finally, the altered EDA•EDA2R signalling would impact on the remodelling of SNSTAA tunica media. Altogether, our results pave the way to a deeper molecular understanding of SNSTAAs necessary to identify their early diagnostic biochemical markers.

Keywords

Thoracic aorta aortic aneurysm extracellular matrix cell signalling gene expression remodelling

Get full access to this article

View all access options for this article.

References

Erbel

et al.

2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J 2014; 35: 2873–2926.

Andelfinger

et al.

A decade of discovery in the genetic understanding of thoracic aortic disease. Can J Cardiol 2016; 32: 13–25.

et al.

Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 2008; 136: 922–929.

Rabkin

. The role of matrix metalloproteinases in the production of aortic aneurysm. Prog Mol Biol Transl Sci 2017; 147: 239–265.

Barnes

. Collagens in atherosclerosis. Coll Relat Res 1985; 5: 65–97.

Carragher

et al.

Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin. J Cell Biol 1999; 147: 619–630.

Turner

. Paxillin: A cytoskeletal target for tyrosine kinases. Bioessays 1994; 16: 47–52.

Olsen

Collagen biosynthesis. In: Hay

(ed). Cell biology of the extracellular matrix, New York: Plenum, 1991, pp. 183–192.

Kanzaki

et al.

Transforming growth factor-beta receptor and fibronectin expressions in aortic smooth muscle cells in diabetic rats. Diabetologia 1997; 40: 383–391.

10.

De Figueiredo Borges

et al.

Collagen is reduced and disrupted in human aneurysms and dissections of ascending aorta. Hum Pathol 2008; 39: 437–443.

11.

Van Keulen

et al.

The role of type III collagen in the development of familial abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1999; 18: 65–70.

12.

Van den Berg

et al.

Type III collagen deficiency in saccular intracranial aneurysms. Defect in gene regulation?

Stroke 1999; 30: 1628–1631.

13.

Tang

et al.

Hyperplastic cellular remodeling of the media in ascending thoracic aortic aneurysms. Circulation 2005; 112: 1098–1105.

14.

Scott

et al.

Light and X-ray scattering show decorin to be a dimer in solution. J Biol Chem 2003; 278: 18353–18359.

15.

Iozzo

et al.

Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999; 274: 4489–4492.

16.

Hildebrand

et al.

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994; 302: 527–534.

17.

Schönherr

et al.

Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. Arch Biochem Biophys 1998; 355: 241–248.

18.

Nili

et al.

Decorin inhibition of PDGF-stimulated vascular smooth muscle cell function: Potential mechanism for inhibition of intimal hyperplasia after balloon angioplasty. Am J Pathol 2003; 163: 869–878.

19.

Theocharis

et al.

Decreased biglycan expression and differential decorin localization in human abdominal aortic aneurysms. Atherosclerosis 2002; 165: 221–230.

20.

Deakin

et al.

Paxillin comes of age. J Cell Sci 2008; 121: 2435–2444.

21.

Pilop

et al.

Proteomic analysis in aortic media of patients with Marfan syndrome reveals increased activity of calpain 2 in aortic aneurysms. Circulation 2009; 120: 983–991.

22.

Ikonomidis

et al.

Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves. J Thorac Cardiovasc Surg 2007; 133: 1028–1036.

23.

Diagne

et al.

Paxillin-associated focal adhesion involvement in perinatal pulmonary arterial remodelling. Matrix Biol 2003; 22: 193–205.

24.

Kielty

et al.

Elastic fibres. J Cell Sci 2002; 115: 2817–2828.

25.

Lemaire

et al.

Microfibril-associated MAGP-2 stimulates elastic fiber assembly. J Biol Chem 2007; 282: 800–808.

26.

Weinbaum

et al.

Deficiency in microfibril-associated glycoprotein-1 leads to complex phenotypes in multiple organ systems. J Biol Chem 2008; 283: 25533–25543.

27.

Miyamoto

et al.

Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch1 extracellular domain dissociation and receptor activation. J Biol Chem 2006; 281: 10089–10097.

28.

Chiarini A, et al. Studies on sporadic non-syndromic thoracic aortic aneurysms. 1. Deregulation of Jagged/Notch 1 homeostasis and selection of synthetic/secretor phenotype smooth-muscle cells. Eur J Prev Cardiol 2018; DOI: 10.1177/2047487318759119.

29.

Chen

et al.

Functional analysis of zebrafish microfibril-associated glycoprotein-1 (Magp1) in vivo reveals roles for microfibrils in vascular development and function. Blood 2006; 107: 4364–4374.

30.

Bonnet

et al.

Structure and cellular distribution of mouse brain testican. Association with the postsynaptic area of hippocampus pyramidal cells. J Biol Chem 1996; 271: 4373–4380.

31.

Marr

et al.

Endothelial cell expression of testican mRNA. Endothelium 1997; 5: 209–219.

32.

Vannahme

et al.

Molecular cloning of testican-2: Defining a novel calcium-binding proteoglycan family expressed in brain. J Neurochem 1999; 73: 12–20.

33.

Alliel

et al.

Testican, a multidomain testicular proteoglycan resembling modulators of cell social behaviour. Eur J Biochem 1993; 214: 347–350.

34.

Nakada

et al.

Suppression of membrane-type 1 matrix metalloproteinase (MMP)-mediated MMP-2 activation and tumor invasion by testican 3 and its splicing variant gene product, N-Tes. Cancer Res 2001; 61: 8896–8902.

35.

Ruoslahti

et al.

Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867–869.

36.

BaSalamah

et al.

Testican in human blood. Biochem Biophys Res Commun 2001; 25: 1083–1090.

37.

Yan

et al.

Identification of a novel death domain-containing adaptor molecule for ectodysplasin-A receptor that is mutated in crinkled mice. Curr Biol 2002; 12: 409–413.

38.

Kere

et al.

X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet 1996; 13: 409–416.

39.

Sinha

et al.

Role of Traf3 and -6 in the activation of the NF-κB and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem 2002; 277: 44953–44961.

40.

Tanikawa

et al.

XEDAR as a putative colorectal tumor suppressor that mediates p53-regulated anoikis pathway. Oncogene 2009; 28: 3081–3092.

41.

Harris

et al.

Zebrafish eda and edar mutants reveal conserved and ancestral roles of ectodysplasin signaling in vertebrates. PLoS Genet 2008; 4: e1000206–e1000206.

42.

Hutson

et al.

Neural crest and cardiovascular development: A 20-year perspective. Birth Defects Res C Embryo Today 2003; 69: 2–13.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.25 MB